
人 TNRC18 抗体对
01AB00609
Trinucleotide repeat containing 18 (TNRC18) is a protein encoded by the TNRC18 gene in humans. The protein has a length of 2968 amino acids, with a predicted molecular weight of 315 kDa. It contains a Bromo Adjacent Homology (BAH) domain, which is often found in chromatin-associated proteins and assists in gene silencing. TNRC18 is predicted to enable chromatin binding activity and is located in the cytosol, mitochondrion, and nucleus. The gene is ubiquitously expressed, with prominent expression in the colon, kidney, prostate, brain, endocrine tissue, and muscle tissue. Diseases associated with TNRC18 include Fazio-Londe Disease and Nephrogenic Adenoma of the Urinary Bladder. The protein has various post-translational modifications, including phosphorylation, sumoylation, palmitoylation, methylation, and glycation sites.
| 规格 | 起售价 |
|---|---|
| 登录后可查看 | |
技术参数
- 靶点基因名
- TNRC18
- 基因别名
- CAGL79; KIAA1856
- 蛋白别名
- trinucleotide repeat containing 18; TNRC18
- UniProt
- O15417
- 物种
- Human
产品详情
- 靶点名称
- TNRC18
- 蛋白名称
- trinucleotide repeat containing 18
- 蛋白别名
- Trinucleotide repeat-containing gene 18 protein; Long CAG trinucleotide repeat-containing gene 79 protein
- 靶点基因名
- TNRC18
- 基因别名
- CAGL79; KIAA1856
- UniProt
- O15417
- 来源物种
- Homo sapiens (Human)
- 物种反应性
- Human
背景介绍
Trinucleotide repeat containing 18 (TNRC18) is a protein encoded by the TNRC18 gene in humans. The protein has a length of 2968 amino acids, with a predicted molecular weight of 315 kDa. It contains a Bromo Adjacent Homology (BAH) domain, which is often found in chromatin-associated proteins and assists in gene silencing. TNRC18 is predicted to enable chromatin binding activity and is located in the cytosol, mitochondrion, and nucleus. The gene is ubiquitously expressed, with prominent expression in the colon, kidney, prostate, brain, endocrine tissue, and muscle tissue. Diseases associated with TNRC18 include Fazio-Londe Disease and Nephrogenic Adenoma of the Urinary Bladder. The protein has various post-translational modifications, including phosphorylation, sumoylation, palmitoylation, methylation, and glycation sites.